the brain's resident immune cells, and have identified it as a promising therapeutic target for Alzheimer’s disease. “Immune checkpoint inhibitors have revolutionized cancer immunotherapy ...

Therefore, CRFBP may represent a valuable target to treat stress-related illness, including: development of novel medications to treat AUD and restore homeostasis in the aging brain. This narrative ...